HealthEquity, Inc. (HQY) Director Sells $27521106.48 in Stock

Postado Agosto 13, 2017

They now have $54.00 target price on the stock. The Firm is engaged in technology-enabled services platforms that allow clients to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where clients can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Takes Position in HealthEquity, Inc.

Analysts expect Healthequity Inc (NASDAQ:HQY) to report $0.14 EPS on September, 5.They anticipate $0.00 EPS change or 0.00% from last quarter's $0.14 EPS. Barrington Research maintained the stock with "Outperform" rating in Wednesday, March 23 report. The Firm sells its products into markets, including smart television, media connectivity, set-top box and Internet of Things devices. Zacks Investment Research's EPS calculations are an average based on a survey of sell-side research analysts that that provide coverage for HealthEquity. Cantor Fitzgerald began coverage on shares of HealthEquity in a report on Thursday, March 30th. Chardan Capital raised their target price on shares of HealthEquity from $53.00 to $57.00 and gave the stock a buy rating in a research note on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company's stock. The stock now has an average rating of "Buy" and a consensus price target of $50.22. Aureus Asset Management Llc acquired 60,330 shares as Healthequity Inc Com (HQY)'s stock rose 4.44%. The stock has a market capitalization of $2.69 billion, a P/E ratio of 84.45 and a beta of 1.73. The stock is trading at $44.93 well below $48.92, the 50 day moving average and a tad under the 200 day moving average of $46.14. HealthEquity has a 52 week low of $28.39 and a 52 week high of $54.95.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.16 by $0.03. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. The firm had revenue of $55.40 million for the quarter, compared to analysts' expectations of $54.77 million. During the same quarter in the previous year, the company posted $0.15 EPS. The company's revenue for the quarter was up 25.9% on a year-over-year basis. Equities analysts forecast that HealthEquity will post $0.58 EPS for the current fiscal year.

"TRADEMARK VIOLATION WARNING: "$0.14 EPS Expected for HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and global trademark and copyright law. The original version of this article can be read at

In other news, VP Ashley Dreier sold 10,000 shares of HealthEquity stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $52.80, for a total transaction of $13,112,932.80.

In other HealthEquity news, major shareholder Berkley Capital, Llc sold 4,002 shares of HealthEquity stock in a transaction dated Monday, June 19th. (NASDAQ:HQY) recently. Stephen Neeleman, Founder and Vice Chairman disclosed the sale of 8,500 shares. 579,253 shares of the company traded hands. Institutional investors and hedge funds own 90.26% of the company's stock. Exane Derivatives bought a new position in shares of HealthEquity during the second quarter valued at about $132,000. FMR LLC now owns 1,248,441 shares of the company's stock valued at $50,587,000 after buying an additional 680,671 shares during the last quarter. Alps Advisors Inc. boosted its stake in shares of HealthEquity by 0.3% in the second quarter. The Nicholas Investment Partners Lp holds 154,851 shares with $6.27 million value, up from 120,633 last quarter. The New York-based New Amsterdam Partners Llc Ny has invested 0.89% in the stock. Arcadia Investment Management Corp MI now owns 2,515 shares of the company's stock valued at $107,000 after buying an additional 1,131 shares during the period. Aureus Asset Management LLC boosted its stake in HealthEquity by 4.9% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company's stock valued at $1,357,000 after buying an additional 112 shares during the period.